Loading...
XJPX3353
Market cap51mUSD
Jan 17, Last price  
2,150.00JPY
1D
1.51%
1Q
-2.80%
Jan 2017
-25.61%
Name

Medical Ikkou Group Co Ltd

Chart & Performance

D1W1MN
XJPX:3353 chart
P/E
7.78
P/S
0.20
EPS
276.41
Div Yield, %
1.86%
Shrs. gr., 5y
-0.37%
Rev. gr., 5y
5.03%
Revenues
39.90b
+17.71%
16,068,897,00017,184,767,00017,974,013,00019,576,619,00020,574,659,00022,873,542,00026,387,273,00029,305,786,00029,489,669,00030,914,968,00031,222,175,00032,042,454,00031,603,667,00033,595,990,00033,897,598,00039,900,988,000
Net income
1.04b
+36.89%
329,224,000457,331,000512,718,000624,059,000790,939,000685,745,000797,468,000910,584,000956,043,0001,238,263,000711,649,000801,993,000834,993,000852,328,000759,598,0001,039,787,000
CFO
4.28b
+227.12%
588,260,000901,066,000780,935,0001,092,069,000828,644,0001,232,428,0001,011,483,0001,555,249,000659,381,0001,426,691,000516,465,0001,823,323,0001,822,603,0001,135,046,0001,307,596,0004,277,397,000
Dividend
Feb 27, 202525 JPY/sh
Earnings
Apr 04, 2025

Profile

Medical Ikkou Group Co.,Ltd. operates dispensing pharmacies in Japan. The company is also involved in the operation of nursing homes, outpatient nursing care facilities, and home-visit nursing care facilities; wholesale of generic drugs; and rental of real estate properties, as well as invests in listed and unlisted stocks, M&A, etc. It operates 93 dispensing pharmacy stores. The company was founded in 1980 and is headquartered in Tsu, Japan.
URL
https://www.m-ikkou.co.jp/
IPO date
Nov 26, 2004
Employees
1,297
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑022023‑022022‑022021‑022020‑022019‑022018‑022017‑022016‑022015‑02
Income
Revenues
39,900,988
17.71%
33,897,598
0.90%
33,595,990
6.30%
Cost of revenue
37,892,873
32,427,626
31,746,394
Unusual Expense (Income)
NOPBT
2,008,115
1,469,972
1,849,596
NOPBT Margin
5.03%
4.34%
5.51%
Operating Taxes
581,070
540,477
607,081
Tax Rate
28.94%
36.77%
32.82%
NOPAT
1,427,045
929,495
1,242,515
Net income
1,039,787
36.89%
759,598
-10.88%
852,328
2.08%
Dividends
(150,303)
(150,261)
(150,243)
Dividend yield
1.71%
1.54%
1.57%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
3,694,000
2,864,980
3,732,395
Long-term debt
6,050,692
6,442,344
7,787,145
Deferred revenue
Other long-term liabilities
1,530,207
1,190,540
1,170,285
Net debt
(62,732)
496,278
1,516,530
Cash flow
Cash from operating activities
4,277,397
1,307,596
1,135,046
CAPEX
(949,582)
(347,458)
(337,046)
Cash from investing activities
(3,218,889)
(477,521)
(215,520)
Cash from financing activities
277,758
(2,366,769)
64,743
FCF
1,411,343
901,356
1,135,945
Balance
Cash
7,700,231
6,443,169
7,992,461
Long term investments
2,107,193
2,367,877
2,010,549
Excess cash
7,812,375
7,116,166
8,323,210
Stockholders' equity
13,296,789
12,066,399
11,410,422
Invested Capital
17,137,109
15,610,616
15,807,516
ROIC
8.72%
5.92%
7.90%
ROCE
8.05%
6.47%
7.66%
EV
Common stock shares outstanding
3,758
3,757
3,756
Price
2,335.00
-9.81%
2,589.00
1.53%
2,550.00
-15.28%
Market cap
8,774,251
-9.79%
9,725,949
1.55%
9,577,953
-15.66%
EV
9,311,860
10,780,736
11,660,666
EBITDA
2,791,991
2,311,557
2,720,068
EV/EBITDA
3.34
4.66
4.29
Interest
54,018
50,805
58,266
Interest/NOPBT
2.69%
3.46%
3.15%